+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 2Years - 18Years
All Genders
Healthy Volunteers
ID05820802

Study of Immune Cells in Children Ages 2 to 18 Undergoing Surgery with Rocuronium Anesthesia Using Single-Cell RNA Analysis to Understand Allergic Reactions to Neuromuscular Blockers

Led by Seoul National University Hospital · Updated on 2024-11-29

294

Participants Needed

1

Research Sites

34 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying immune cells in children aged 2 to 18 who are undergoing general anesthesia and surgery with the neuromuscular blocker rocuronium. The goal is to use single-cell RNA sequencing to analyze immune cells, especially T lymphocytes, in those who might have allergic reactions to this medication. This observational study focuses on understanding immune responses in pediatric patients during such surgeries. The study involves observing pediatric patients expected to receive rocuronium during general anesthesia. There are no drug treatments or interventions being tested directly instead, blood samples will be collected during surgery to perform transcriptomic analysis of immune cells. The primary outcome is to analyze the transcriptomic profile of T lymphocytes by RNA sequencing until the end of surgery, typically up to 12 hours after the first dose of rocuronium. Participants will be monitored during their surgical procedure with blood samples taken for laboratory analysis. No additional treatments or interventions are administered as part of the study. Researchers will assess immune cell profiles through RNA sequencing to better understand allergic reactions linked to neuromuscular blockers. The study is led by Seoul National University Hospital and is expected to continue until December 2026.

CONDITIONS

Brief Title

High Dimensional Analysis of Immune Cells in Pediatric Patients

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here